CHRYSALON
Mark Identification

CHRYSALON

Serial Number

79070785

Filing Date

Mar 26, 2009

Registration Date

May 25, 2010

Trademark by

INSTITUT DE RECHERCHE PIERRE FABRE

Classification Information

Chemical products for industrial and scientific purposes, especially collections of organic molecules, namely, for use in the manufacture of pharmaceuticals, namely, anti-tumor agents, anti-infective agents, antibiotics, anti-viral agents, anti-inflammatory agents, anti-diabetics, anti-blood coagulation agents, bone disease agents, cardio-vascular disease agents, disinfectants, gastro-intestinal agents, immuno-modulating agents, liver disease agents, lung disease agents, metabolism disease agents, neurological agents, psycho-pharmacological agents, renal-urological agents; chemicals products, namely, collections of organic molecules for use in the manufacture of agrochemicals, cosmetics, animal health products

Chemicals

Pharmaceutical and veterinary preparations, especially collections of organic molecules, namely, anti-tumor agents, anti-infective agents, antibiotics, antiviral agents, anti-inflammatory agents, anti-diabetics, anti-blood coagulation agents, bone disease agents, cardio-vascular disease agents, disinfectants, dermatological agents, gastro-intestinal agents, immuno-modulating agents, liver disease agents, lung disease agents, metabolism disease agents, neurological agents, psycho-pharmacological agents, renal-urological agents; chemicals products, namely, collections of organic molecules used in the manufacture of agrochemicals, fungicidal agents, herbicidal agents, insecticidal agents, growth-modulating agents

Pharmaceuticals

Scientific research services, namely, optimization, synthesis and modeling of molecules, biological analyses, preparation and performance of biological tests; design and synthesis for others of new organic molecules with potential therapeutic and agro-chemical interest; design and performance of in-vitro high flow rate tests for others for the discovery of protein-ligand interactions with a view to developing medication candidates

Computer and Scientific